Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51-Reference-Cited by-同舟云学术

Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51

Published:1992-10 Issue:2 Volume:35 Page:85-92
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Bouma Geertruida J.,van der Meer-Prins Petronella M.W.,van Bree Francina P.M.J.,van Rood Jon J.,Claas Frans H.J.

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference32 articles.

1. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogeneic target cells in vitro: inhibition by isoantibody and drugs;Brunner;Immunology,1968

2. Carboxyfluorescein fluorochromasia assays. I. Non-radioactively labelled cell mediated lympholysis;Bruning;J Immunol Methods,1980

3. Carboxyfluorescein fluorochromasia cell-mediated lympholysis: a comparative study;Van der Poel;Immunol Lett,1981

4. Automated fluorometric assay for T cell cytotoxicity;Brenan;J Immunol Methods,1988

5. Measurement of lymphocyte cytotoxicity by assessing endogenous alkaline phosphatase activity of the target cells;Szekeres;J Immunol Methods,1981

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of an Essential IL15-STAT1-IRX3 Prosurvival Pathway in T Lymphocytes with Therapeutic Implications;2017-08-21

2. Identification of Donor Origin and Condition of Transplanted Islets in Situ in the Liver of a Type 1 Diabetic Recipient;Cell Transplantation;2017-01

3. Lysis-on-Chip of Single Target Cells following Forced Interaction with CTLs or NK Cells on a Dielectrophoresis-Based Array;The Journal of Immunology;2013-09-04

4. Immune responses against islet allografts during tapering of immunosuppression – a pilot study in 5 subjects;Clinical and Experimental Immunology;2012-07-06

5. Immunological Aspects of Allogeneic and Autologous Mesenchymal Stem Cell Therapies;Human Gene Therapy;2011-12